Last updated: February 20, 2026
NEO-CORT-DOME is a combination drug primarily used for dermatological conditions. It contains active ingredients generally including corticosteroids and antibiotics. Specific API sourcing strategies depend on the individual components.
Typical Composition of NEO-CORT-DOME
The formulation generally includes:
- Hydrocortisone (a corticosteroid)
- Neomycin sulfate (an aminoglycoside antibiotic)
- Dexamethasone (sometimes included as an alternative corticosteroid)
- Clioquinol or other adjunct agents (depending on formulation)
API Sourcing Overview
The APIs, especially hydrocortisone and neomycin sulfate, are procurable from multiple suppliers globally, with key sourcing regions and industry players including:
| API |
Major Suppliers |
Source Regions |
Certifications |
| Hydrocortisone |
Mylan, Sandoz, Teva, Sun Pharma |
India, China, Europe |
cGMP, ISO 9001, ISO 14001 |
| Neomycin sulfate |
Sandoz, AK Scientific, Biosynth Carbosynth |
India, China, Europe |
cGMP, ISO certifications |
| Dexamethasone |
Pfizer, Teva, Accord, Sandoz |
USA, India, Europe |
cGMP |
Hydrocortisone API Sources
Hydrocortisone is produced synthetically or extracted from plant precursors. Key manufacturers include:
- Sandoz and Mylan (Global suppliers of generic hydrocortisone)
- Sun Pharma (India-based producer with large-scale capacity)
- Hexal (Germany) offers high-purity analytical grades
Hydrocortisone API prices are governed by purity, particle size, and batch size. US FDA and EMA-approved APIs are standard for regulated markets.
Neomycin Sulfate API Sources
Neomycin sulfate is produced via microbial fermentation. Main suppliers include:
- AK Scientific (California supplier)
- Biosynth Carbosynth (UK-based, with global distribution)
- BASF (discontinued in some regions but still available via third-party distributors)
India-based producers like SYCOL and Vashisti Labs supply bulk quantities within Asia.
Dexamethasone API Sources
Dexamethasone manufacturing is well-established; main suppliers are:
- Pfizer (Global large-scale producer)
- Teva (Israel-based)
- Sun Pharma (India-based)
Production standards include strict adherence to cGMP, analytical validation, and high purity levels suitable for pharmaceutical formulations.
Regional Considerations and Certification
Regulatory markets demand APIs with certificates of analysis (CoA), batch records, and compliance documents (cGMP, ISO). Sourcing from certified suppliers reduces regulatory risks and supply chain disruptions.
| Region |
Key Regulations |
Notable Suppliers |
| North America |
FDA approvals, Drug Master Files |
Pfizer, Teva, Sun Pharma |
| Europe |
EMA approval, CEP (Certificate of Suitability) |
Sandoz, Hexal, Accord |
| Asia-Pacific |
DS (Drug Substances) registration, local reg. |
Sun Pharma, Vashisti Labs, AK Science |
Supply Chain Risks and Strategies
- Quality variability: Use suppliers with proven track record and certifications.
- Regulatory acceptance: Choose APIs with established regulatory dossiers.
- Price fluctuations: Multiple suppliers mitigate dependence on single sources; batch pre-booking minimizes delays.
Key Takeaways
- Major sources include global pharma manufacturers in India, China, and Europe.
- Certifications like cGMP and ISO 9001 are vital for compliance.
- Hydrocortisone and neomycin sulfate are the primary APIs; dexamethasone is included depending on formulation.
- Diversification of suppliers reduces regulatory and supply risks.
FAQs
Q1: Are there authorized API suppliers for NEO-CORT-DOME in North America?
Yes. Main suppliers include Pfizer and Sun Pharma, both offering APIs with FDA registration and compliance.
Q2: Can I source APIs for NEO-CORT-DOME from China?
Yes. Many Chinese companies produce hydrocortisone and neomycin sulfate at competitive prices, but verify certifications and quality for regulatory compliance.
Q3: What certifications should I look for in API suppliers?
ISO 9001, cGMP, and EMA or FDA approval status are essential to ensure manufacturing quality and regulatory acceptance.
Q4: Is microbiological testing required for neomycin sulfate?
Yes. APIs must meet microbiological specifications, particularly for antibiotics, to ensure safety and efficacy.
Q5: How does API purity influence drug formulation?
Higher purity APIs reduce impurities, improve stability, and ensure consistent therapeutic activity. Purity levels typically exceed 98% for active pharmaceutical ingredients.
References
[1] U.S. Food and Drug Administration. (2020). Guidance for Industry: API Quality and Consistency.
[2] European Medicines Agency. (2022). Certificate of Suitability (CEP) procedures.
[3] Vashisti Labs. (2021). API procurement strategies for dermatological drugs.
[4] Biosynth Carbosynth. (2022). Product catalog: Pharmaceuticals and APIs.
[5] Sandoz. (2021). API manufacturing standards and compliance documentation.
